Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 25 results.
User Information
Export Records
  1. 1.   Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21
  2. Ostrom, Quinn T.; Kinnersley, Ben; Wrensch, Margaret R.; Eckel-Passow, Jeanette E.; Armstrong, Georgina; Rice, Terri; Chen, Yanwen; Wiencke, John K.; McCoy, Lucie S.; Hansen, Helen M.; Amos, Christopher I.; Bernstein, Jonine L.; Claus, Elizabeth B.; Il'yasova, Dora; Johansen, Christoffer; Lachance, Daniel H.; Lai, Rose K.; Merrell, Ryan T.; Olson, Sara H.; Sadetzki, Siegal; Schildkraut, Joellen M.; Shete, Sanjay; Rubin, Joshua B.; Lathia, Justin D.; Berens, Michael E.; Andersson, Ulrika; Rajaraman, Preetha; Chanock, Stephen; Linet, Martha; Wang, Zhaoming; Yeager, Meredith; Houlston, Richard S.; Jenkins, Robert B.; Melin, Beatrice; Bondy, Melissa L.; Barnholtz-Sloan, Jill. S.
  3. Scientific Reports. 2018, May 9; 8(1): 7352.
  1. 2.   JS-K, a Glutathione S-Transferase-Activated Nitric Oxide Donor With Antineoplastic Activity in Malignant Gliomas
  2. Weyerbrock, A.; Osterberg, N.; Psarras, N.; Baumer, B.; Kogias, E.; Werres, A.; Bette, S.; Saavedra, J. E.; Keefer, L. K.; Papazoglou, A.
  3. Neurosurgery. 2012, Feb; 70(2): 497-510.
  1. 3.   Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma
  2. Teider, N.; Scott, D. K.; Neiss, A.; Weeraratne, S. D.; Amani, V. M.; Wang, Y. F.; Marquez, V. E.; Cho, Y. J.; Pomeroy, S. L.
  3. Neuro-Oncology. 2010, Dec; 12(12): 1244-+.
  1. 4.   Risk of Meningioma and Common Variation in Genes Related to Innate Immunity
  2. Rajaraman, P.; Brenner, A. V.; Neta, G.; Pfeiffer, R.; Wang, S. S.; Yeager, M.; Thomas, G.; Fine, H. A.; Linet, M. S.; Rothman, N.; Chanock, S. J.; Inskip, P. D.
  3. Cancer Epidemiology Biomarkers & Prevention. 2010, May; 19(5): 1356-1361.
  1. 5.   DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma
  2. Rajaraman, P.; Hutchinson, A.; Wichner, S.; Black, P. M.; Fine, H. A.; Loeffler, J. S.; Selker, R. G.; Shapiro, W. R.; Rothman, N.; Linet, M. S.; Inskip, P. D.
  3. Neuro-Oncology. 2010, Jan; 12(1): 37-48.
  1. 6.   Ultrasmall superparamagnetic iron oxides (USPIOs): a future alternative magnetic resonance (MR) contrast agent for patients at risk for nephrogenic systemic fibrosis (NSF)?
  2. Neuwelt, E. A.; Hamilton, B. E.; Varallyay, C. G.; Rooney, W. R.; Edelman, R. D.; Jacobs, P. M.; Watnick, S. G.
  3. Kidney International. 2009 75(5): 465-474.
  1. 7.   Common Variation in Genes Related to Innate Immunity and Risk of Adult Glioma
  2. Rajaraman, P.; Brenner, A. V.; Butler, M. A.; Wang, S. S.; Pfeiffer, R. M.; Ruder, A. M.; Linet, M. S.; Yeager, M.; Wang, Z. M.; Orr, N.; Fine, H. A.; Kwon, D.; Thomas, G.; Rothman, N.; Inskip, P. D.; Chanock, S. J.
  3. Cancer Epidemiology Biomarkers & Prevention. 2009 18(5): 1651-1658.
  1. 8.   Substitution of Aminomethyl at the Meta-Position Enhances the Inactivation of O-6-Alkylguanine-DNA Alkyltransferase by O-6-Benzylguanine
  2. Pauly, G. T.; Loktionova, N. A.; Fang, Q. M.; Vankayala, S. L.; Guida, W. C.; Pegg, A. E.
  3. Journal of Medicinal Chemistry. 2008 51(22): 7144-7153.
  1. 9.   Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma
  2. Yi, L.; Zhou, Z. H.; Ping, Y. F.; Chen, J. H.; Yao, X. H.; Feng, H.; Lu, J. Y.; Wang, J. M.; Bian, X. W.
  3. Modern Pathology. 2007, Oct; 20(10): 1061-1068.
  1. 10.   The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiograpgy in central nervous system malignancy: A pilot study
  2. Neuwelt, E. A.; Varallyay, C. G.; Manninger, S.; Solymosi, D.; Haluska, M.; Hunt, M. A.; Nesbit, G.; Stevens, A.; Jerosch-Herold, M.; Jacobs, P. M.; Hoffman, J. M.
  3. Neurosurgery. 2007, Apr; 60(4): 601-611.
  1. 11.   Environmental genotoxicants/carcinogens and childhood cancer: Bridgeable gaps in scientific knowledge
  2. Anderson, L. M.
  3. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2006, Sep; 608(2): 136-156.
  1. 12.   Delivery of gadolinium-labeled nanoparticles to the sentinel lymph node: Comparison of the sentinel node visualization and estimations of intra-nodal gadolinium concentration by the magnetic resonance imaging
  2. Kobayashi, H.; Kawamoto, S.; Bernardo, M.; Brechbiel, M. W.; Knopp, M. V.; Choyke, P. L.
  3. Journal of Controlled Release. 2006, Apr; 111(3): 343-351.
  1. 13.   Expression of hypoxia-inducible carbonic anhydrases in brain tumors
  2. Proescholdt, M. A.; Mayer, C.; Kubitza, M.; Schubert, T.; Liao, S. Y.; Stanbridge, E. J.; Ivanov, S.; Oldfield, E. H.; Brawanski, A.; Merrill, M. J.
  3. Neuro-Oncology. 2005, OCT; 7(4): 465-475.
  1. 14.   Common variants in selected metabolic genes and the risk of adult brain tumors
  2. De Roos, A. J.; Rothman, N.; Brown, M.; Inskip, P. D.
  3. Cancer Epidemiology Biomarkers & Prevention. 2004, NOV; 13(11, Part 2): 1898S-1899S.
  1. 15.   The importance of genome architecture in cancer susceptibility - Location, location, location
  2. Reilly, K. M.
  3. Cell Cycle. 2004, NOV; 3(11): 1378-1382.
  1. 16.   The mutagenic effects of 7,12-dimethylbenz[a]anthacene, 3-methylcholanthrene and benzo[a]pyrene to the developing Syrian hamster fetus measured by an in vivo/in vitro mutation assay
  2. Donovan, P. J.; Smith, G. T.; Nardone, R.
  3. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2004, OCT 4; 554(1-2): 111-120.
  1. 17.   Brain tumor cell lines resistant to O-6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O-6 -alkylguanine-DNA alkyltransferase mutations
  2. Bacolod, M. D.; Johnson, S. P.; Pegg, A. E.; Dolan, M. E.; Moschel, R. C.; Bullock, N. S.; Fang, Q. M.; Colvin, O. M.; Modrich, P.; Bigner, D. D.; Friedman, H. S.
  3. Molecular Cancer Therapeutics. 2004, SEP; 3(9): 1127-1135.
  1. 18.   Selective opening of the blood-tumor barrier by a nitric oxide donor and long-term survival in rats with C6 gliomas
  2. Weyerbrock, A.; Walbridge, S.; Pluta, R. M.; Saavedra, J. E.; Keefer, L. K.; Oldfield, E. H.
  3. Journal of Neurosurgery. 2003 99(4): 728-737.
  1. 19.   Pharmacokinetics and organ distribution of N- methanocarbathymidine, a novel thymidine analog, in mice bearing tumors transduced with the herpes simplex thymidine kinase gene
  2. Noy, R.; Ben-Zvi, Z.; Elezra, M.; Candotti, F.; Ford, H.; Morris, J. C.; Marquez, V. E.; Johns, D. G.; Agbaria, R.
  3. Cancer Chemotherapy and Pharmacology. 2002 50(5): 360-366.
  1. 20.   A multicenter evaluation of assays for detection of SV40 DNA and results in masked mesothelioma specimens
  2. Strickler, H. D.; Goedert, J. J.; Butel, J. S.; Daniel, R.; Freymuth, F.; Gibbs, A.; Griffiths, D. J.; Jablons, D.; Jasani, B.; Jones, C.; Lednicky, J. A.; Miller, C. W.; Radu, C.; Richards, W. G.; Shah, K. V.; You, L.; Corson, J. M.; Gerwin, B.; Harris, C.; Sugarbaker, D. J.; Egan, W.; Lewis, A. M.; Krause, P. R.; Peden, K.; Levine, A. S.; Melnick, S.; Cosentino, M.; da Costa, M.; Devairrakam, V.; Ji, J.; Palefsky, J.; Rasmussen, L.; Shea, K.; Wacholder, S.; Waters, D.; Wright, T.
  3. Cancer Epidemiology Biomarkers & Prevention. 2001 10(5): 523-532.
  1. 21.   Comparative molecular genetic profiles of anaplastic astrocytomas glioblastomas multiforme and their subsequent recurrences
  2. Saxena, A.; Shriml, L. M.; Dean, M.; Ali, I. U.
  3. Oncogene. 1999 18(6): 1385-1390.
  1. 22.   Phase I Trial of O-6-Benzylguanine For Patients Undergoing Surgery For Malignant Glioma
  2. Friedman, H. S.; Kokkinakis, D. M.; Pluda, J.; Friedman, A. H.; Cokgor, I.; Haglund, M. M.; Ashley, D. M.; Rich, J.; Dolan, M. E.; Pegg, A. E.; Moschel, R. C.; McLendon, R. E.; Kerby, T.; Herndon, J. E.; Bigner, D. D.; Schold, S. C.
  3. Journal of Clinical Oncology. 1998 16(11): 3570-3575.
  1. 23.   Intraarterial O-6-Benzylguanine Enables the Specific Therapy of Nitrosourea-Resistant Intracranial Human Glioma Xenografts in Athymic Rats With 1,3-Bis(2-Chloroethyl)-1-Nitrosourea
  2. Kurpad, S. N.; Dolan, M. E.; McLendon, R. E.; Archer, G. E.; Moschel, R. C.; Pegg, A. E.; Bigner, D. D.; Friedman, H. S.
  3. Cancer Chemotherapy and Pharmacology. 1997 39(4): 307-316.
  1. 24.   Nerve Growth Factor Induces Apoptosis in Human Medulloblastoma Cell Lines That Express Trka Receptors
  2. Muragaki, Y.; Chou, T. T.; Kaplan, D. R.; Trojanowski, J. Q.; Lee, V. M. Y.
  3. Journal of Neuroscience. 1997 17(2): 530-542.
  1. 25.   Power Frequency Magnetic Fields Do Not Contribute to Transformation of Jb6 Cells
  2. Saffer, J. D.; Chen, G.; Colburn, N. H.; Thurston, S. J.
  3. Carcinogenesis. 1997 18(7): 1365-1370.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel